Vertex Pharmaceuticals Inc. buy Wolfe Research
Start price
06.01.26
/
50%
€389.95
Target price
06.01.27
€467.39
Performance (%)
-3.41%
Price
14.04.26
€376.65
Summary
This prediction is currently active. With a performance of -3.41%, the BUY prediction for Vertex Pharmaceuticals Inc. by Wolfe_Research is down slightly. This prediction currently runs until 06.01.27. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.643% | -1.643% |
| iShares Core DAX® | 3.023% | 2.202% |
| iShares Nasdaq 100 | 3.561% | 1.325% |
| iShares Nikkei 225® | 6.618% | 5.707% |
| iShares S&P 500 | 2.635% | 1.008% |
Comments by Wolfe_Research for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $548.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Wolfe_Research for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€393.55
15.02.24
15.02.24
€478.13
15.02.25
15.02.25
11.82%
16.02.25
16.02.25
